332 related articles for article (PubMed ID: 35980318)
1. METTL14 Regulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Inducing Autophagy Through m6A/IGF2BPs/Beclin-1 Signal Axis.
He M; Lei H; He X; Liu Y; Wang A; Ren Z; Liu X; Yan G; Wang W; Wang Y; Li G; Wang T; Pu J; Shen Z; Wang Y; Xie J; Du W; Yuan Y; Yang L
Stem Cells Transl Med; 2022 Sep; 11(9):987-1001. PubMed ID: 35980318
[TBL] [Abstract][Full Text] [Related]
2. METTL14 mediates m
Dong X; Liao B; Zhao J; Li X; Yan K; Ren K; Zhang X; Bao X; Guo W
Mol Med Rep; 2023 Sep; 28(3):. PubMed ID: 37449516
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1.
Huang C; Wang Y
Cell Death Dis; 2022 Nov; 13(11):919. PubMed ID: 36319624
[TBL] [Abstract][Full Text] [Related]
4. METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis.
Wang X; Zou C; Li M; Hou C; Jiang W; Bian Z; Zhu L
Hum Cell; 2023 Jan; 36(1):178-194. PubMed ID: 36401086
[TBL] [Abstract][Full Text] [Related]
5. METTL14 benefits the mesenchymal stem cells in patients with steroid-associated osteonecrosis of the femoral head by regulating the m6A level of PTPN6.
Cheng C; Zhang H; Zheng J; Jin Y; Wang D; Dai Z
Aging (Albany NY); 2021 Dec; 13(24):25903-25919. PubMed ID: 34910686
[TBL] [Abstract][Full Text] [Related]
6. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
7. METTL14 alleviates the development of osteoporosis in ovariectomized mice by upregulating m
Wang C; Chen R; Zhu X; Zhang X; Lian N
Bone; 2023 Mar; 168():116652. PubMed ID: 36584783
[TBL] [Abstract][Full Text] [Related]
8. METTL14 represses osteoclast formation to ameliorate osteoporosis via enhancing GPX4 mRNA stability.
Deng M; Luo J; Cao H; Li Y; Chen L; Liu G
Environ Toxicol; 2023 Sep; 38(9):2057-2068. PubMed ID: 37195267
[TBL] [Abstract][Full Text] [Related]
9. METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2.
Zhou S; Zhang G; Wang K; Yang Z; Tan Y
Oral Dis; 2024 Apr; 30(3):1313-1321. PubMed ID: 36705430
[TBL] [Abstract][Full Text] [Related]
10. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation.
Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ
J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744
[TBL] [Abstract][Full Text] [Related]
11. WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.
Liu J; You Y; Sun Z; Zhang L; Li X; Dai Z; Ma J; Chen Y; Jiao G
Stem Cells Transl Med; 2023 May; 12(5):307-321. PubMed ID: 37010483
[TBL] [Abstract][Full Text] [Related]
12. piRNA-36741 regulates BMP2-mediated osteoblast differentiation via METTL3 controlled m6A modification.
Liu J; Chen M; Ma L; Dang X; Du G
Aging (Albany NY); 2021 Oct; 13(19):23361-23375. PubMed ID: 34645714
[TBL] [Abstract][Full Text] [Related]
13. Mettl3 Regulates Osteogenic Differentiation and Alternative Splicing of Vegfa in Bone Marrow Mesenchymal Stem Cells.
Tian C; Huang Y; Li Q; Feng Z; Xu Q
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696066
[TBL] [Abstract][Full Text] [Related]
14. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
[TBL] [Abstract][Full Text] [Related]
15. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
16. Isoliquiritin treatment of osteoporosis by promoting osteogenic differentiation and autophagy of bone marrow mesenchymal stem cells.
Su Z; Chen D; Huang J; Liang Z; Ren W; Zhang Z; Jiang Q; Luo T; Guo L
Phytother Res; 2024 Jan; 38(1):214-230. PubMed ID: 37859562
[TBL] [Abstract][Full Text] [Related]
17. Autophagy Maintains the Function of Bone Marrow Mesenchymal Stem Cells to Prevent Estrogen Deficiency-Induced Osteoporosis.
Qi M; Zhang L; Ma Y; Shuai Y; Li L; Luo K; Liu W; Jin Y
Theranostics; 2017; 7(18):4498-4516. PubMed ID: 29158841
[No Abstract] [Full Text] [Related]
18. METTL3-m
Wu T; Tang H; Yang J; Yao Z; Bai L; Xie Y; Li Q; Xiao J
Cell Prolif; 2022 May; 55(5):e13234. PubMed ID: 35470497
[TBL] [Abstract][Full Text] [Related]
19. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho.
Li M; Deng L; Xu G
Mol Med; 2021 Sep; 27(1):106. PubMed ID: 34503454
[TBL] [Abstract][Full Text] [Related]
20. METTL14-dependent m6A regulates vascular calcification induced by indoxyl sulfate.
Chen J; Ning Y; Zhang H; Song N; Gu Y; Shi Y; Cai J; Ding X; Zhang X
Life Sci; 2019 Dec; 239():117034. PubMed ID: 31697949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
